Navigation Links
CutisPharma Homogeneity and Stability Study for Mouthwash Compounding Kits Presented at NERDG Meeting
Date:5/15/2012

WOBURN, Mass., May 15, 2012 /PRNewswire/ -- CutisPharma, Inc. announced the presentation of homogeneity and stability studies for compounded formulations of several "Magic Mouthwash" suspensions using FIRST®- Unit- of- use Prescription Compounding Kits.  The poster presentation, by Anisa Gandhi, was at the April 20th American Association of Pharmaceutical Scientists, Northeast Regional Discussion Group (NERDG) Regional Meeting.

"Magic Mouthwash" is commonly prescribed by physicians nationwide.  The purpose behind magic mouthwash is to combine various ingredients with different advantages depending on the patient's symptoms.  Currently magic mouthwash is extemporaneously prepared or is prepared using FIRST® - Magic Mouthwash Compounding Kits.

The active ingredients used in these FIRST® Magic Mouthwash kits are comparable to those found in the most routinely prescribed "Magic Mouthwash" formulations.  These active ingredients are: diphenhydramine hydrochloride, lidocaine hydrochloride, and modified Maalox® in FIRST® - Mouthwash BLM; diphenhydramine hydrochloride, lidocaine hydrochloride, and nystatin in FIRST®  -BXN Mouthwash; diphenhydramine hydrochloride, hydrocortisone, and nystatin in FIRST®  - Duke's Mouthwash; and diphenhydramine hydrochloride, hydrocortisone, nystatin, and tetracycline in FIRST®  - Mary's Mouthwash.

Ms. Gandhi's presentation demonstrated that FIRST®  -Mouthwash Kits are uniform in nature for active ingredients.  FIRST®  Magic Mouthwash Kits are convenient with reliable stability and uniformity data, whereas, the traditional compounding process generally does not have this data available.

FIRST® products save dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction.  Using FIRST® Mouthwash kits, the pharmacist can compound a prescription with accuracy faster than those prepared in the conventional way.  A single NDC number assigned for the entire kit facilitates the third party reimbursement process, and reduces audit- related adjustments.

CutisPharma now has twenty proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, six Magic Mouthwash kits, three omeprazole suspension kits, and three lansoprazole suspension kits.  Several more compounding kits are in the planning stages. The use of FIRST® Unit-of-Use Prescription Compounding Kits facilitates compliance with United States Pharmacopeia (USP) Chapter <795>.

"CutisPharma is committed to maintaining the scientific integrity of the products it develops and commercializes.  Studies of this nature also demonstrate the scientific reliability of FIRST® products, as well as confirm their user-friendliness and time-saving benefits" said Dr. Indu Muni, President  & CEO of CutisPharma.

About CutisPharma
CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.

For more information please visit our website at www.cutispharma.com.


'/>"/>
SOURCE CutisPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
2. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
3. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
4. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
5. CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits
6. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
7. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. ADVENTRX Announces 9-Month Stability Data Results for ANX-530
9. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
10. Stability Testing Course is Taking the Online Training Format by Storm!
11. Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec. 9, 2016 Department of Health Secretary ... for medical marijuana dispensaries under Act 16 are slated ... and are now available online . ... the plan for operation; process for dispensing medical marijuana; ... as where the dispensary facilities can be located," said ...
(Date:12/8/2016)... , Dec. 8, 2016 Australia Ophthalmic Lasers ... report, "Australia Ophthalmic Lasers Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segements - Excimer Lasers, Femtosecond Lasers and YAG Lasers. ... shares data for each of these market segements, and ...
(Date:12/8/2016)... , Dec. 8, 2016 Global ... report on the global interventional radiology market analyzes ... The report comprises an elaborate executive summary, including ... various segments and sub-segments. The research is ... research formed the bulk of our research efforts ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Cellairis is a worldwide mobile device and computer ... , iPad and Samsung Galaxy devices with premium parts and accessories. Cellairis ... maximize convenience and accessibility for customers. While customers do their shopping, Cellairis can accomplish ...
(Date:12/9/2016)... ... ... An inventor from Cana, Va., wanted to fulfill the need for a device ... The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. It is also ... a matter of minutes, or even seconds. The SAFETY STRAP FOR AMPUTEES is a ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic Trainers’ ... during the summer of 2016. The program was made possible by a Pennsylvania ... Department of Health and Human Services Administration. The broadcast, Use Your Head: ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , ... Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A ... Results of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
Breaking Medicine News(10 mins):